Medico Remedies Limited (NSE:MEDICO)
56.25
-1.88 (-3.23%)
Mar 13, 2025, 3:29 PM IST
Medico Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | - | 82.91 | 72.42 | 48.12 | 25.9 | 16.3 | Upgrade
|
Depreciation & Amortization | - | 28.79 | 27.21 | 22.18 | 16.5 | 16.64 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -0.03 | 0.01 | 0.39 | - | -0.02 | Upgrade
|
Provision & Write-off of Bad Debts | - | 6.26 | -1.39 | 0.62 | - | - | Upgrade
|
Other Operating Activities | - | 1.49 | 4.91 | 0.74 | 10.8 | 4.86 | Upgrade
|
Change in Accounts Receivable | - | -136.13 | -55.62 | -38.81 | -274.3 | 51.8 | Upgrade
|
Change in Inventory | - | 33.62 | -15.91 | -35.57 | -145.5 | -21.89 | Upgrade
|
Change in Accounts Payable | - | 5.26 | 38.89 | 17.49 | 253.5 | -61.18 | Upgrade
|
Change in Other Net Operating Assets | - | 4.66 | 11.16 | 43.46 | - | 3.17 | Upgrade
|
Operating Cash Flow | - | 26.83 | 81.67 | 58.62 | -113.1 | 9.67 | Upgrade
|
Operating Cash Flow Growth | - | -67.15% | 39.32% | - | - | -80.43% | Upgrade
|
Capital Expenditures | - | -24.78 | -65.92 | -59.13 | -169.6 | -33.29 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.08 | 0.05 | 30.1 | - | 0.03 | Upgrade
|
Investment in Securities | - | -0.98 | -0.87 | -0.14 | - | -3.1 | Upgrade
|
Other Investing Activities | - | -1.09 | 0.71 | 0.6 | - | 3.79 | Upgrade
|
Investing Cash Flow | - | -26.77 | -66.04 | -17.56 | -169.6 | -30.81 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 101 | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 49.5 | 35.07 | Upgrade
|
Total Debt Issued | - | - | - | - | 150.5 | 35.07 | Upgrade
|
Long-Term Debt Repaid | - | -4.9 | -4.6 | -1.5 | - | - | Upgrade
|
Net Debt Issued (Repaid) | - | -4.9 | -4.6 | -1.5 | 150.5 | 35.07 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 41.5 | - | Upgrade
|
Other Financing Activities | - | - | -13.57 | -56.21 | -9.2 | -9.09 | Upgrade
|
Financing Cash Flow | - | -4.9 | -18.17 | -57.71 | 182.8 | 25.98 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | -2.45 | - | - | - | 0 | Upgrade
|
Net Cash Flow | - | -7.29 | -2.54 | -16.65 | -99.9 | 4.84 | Upgrade
|
Free Cash Flow | - | 2.04 | 15.75 | -0.51 | -282.7 | -23.61 | Upgrade
|
Free Cash Flow Growth | - | -87.02% | - | - | - | - | Upgrade
|
Free Cash Flow Margin | - | 0.14% | 1.12% | -0.04% | -23.10% | -2.66% | Upgrade
|
Free Cash Flow Per Share | - | 0.02 | 0.19 | -0.01 | -3.41 | -0.28 | Upgrade
|
Cash Interest Paid | - | - | 0.53 | 2.33 | 9.2 | 8.34 | Upgrade
|
Cash Income Tax Paid | - | 31.66 | 24.95 | 17.95 | 9.3 | 5.43 | Upgrade
|
Levered Free Cash Flow | - | -12.64 | -18.61 | -11.65 | -163.84 | -10.94 | Upgrade
|
Unlevered Free Cash Flow | - | -8.63 | -14.99 | -8.48 | -158.9 | -5.73 | Upgrade
|
Change in Net Working Capital | - | 75.33 | 19.39 | 3.76 | 28.24 | -3.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.